Shire Inks $32B Deal For Baxalta
Dublin-based Shire PLC finally won over U.S. biotech Baxalta with a $32 billion bid Monday, continuing the Irish pharmaceutical giant's aggressive push to build out its rare disease platform....To view the full article, register now.
Already a subscriber? Click here to view full article